These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22161819)

  • 1. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
    Tsou PS; Talia NN; Pinney AJ; Kendzicky A; Piera-Velazquez S; Jimenez SA; Seibold JR; Phillips K; Koch AE
    Arthritis Rheum; 2012 Jun; 64(6):1978-89. PubMed ID: 22161819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.
    Tsou PS; Balogh B; Pinney AJ; Zakhem G; Lozier A; Amin MA; Stinson WA; Schiopu E; Khanna D; Fox DA; Koch AE
    Arthritis Res Ther; 2014; 16(5):411. PubMed ID: 25123250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
    Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
    Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
    Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
    PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.
    Spadoni T; Svegliati Baroni S; Amico D; Albani L; Moroncini G; Avvedimento EV; Gabrielli A
    Arthritis Rheumatol; 2015 Jun; 67(6):1611-22. PubMed ID: 25707572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
    Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
    Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
    Liu T; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.
    Piera-Velazquez S; Makul A; Jiménez SA
    Arthritis Rheumatol; 2015 Oct; 67(10):2749-58. PubMed ID: 26096997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
    Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
    Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
    Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
    Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF Promotes Dermal Fibroblast Activation
    Takamura N; Renaud L; da Silveira WA; Feghali-Bostwick C
    Front Immunol; 2021; 12():745308. PubMed ID: 34912333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.